Join us for a special COVID-19 virtual series hosted by the Geisel School of Medicine and co-sponsored by Dartmouth Alumni Relations and Dartmouth's graduate schools.

Attendees must register for each event separately. Space is limited, so register today!

Future session

Special guest and moderator for all sessions

Susan Dentzer D’77
Senior Policy Fellow
Robert J. Margolis Center for Health Policy, Duke University
Former Chair, Dartmouth Board of Trustees

COVID-19 vaccines have been developed, tested, manufactured, and approved in record time – but delivering them to people who need them has proved challenging in the United States. How did we get these vaccines so quickly? What is behind the slow pace of the rollout? What has been learned from these experiences? Panelists will dig into these questions and more, with an eye on the future.

Kendall Hoyt, PhD
Areas of Expertise: vaccine economics, distribution, and planning

Assistant Professor of Medicine

Geisel School of Medicine

Jake Reder, PhD
Areas of Expertise: biomedical entrepreneurship, academic-industry-government collaboration

CEO, Celdara Medical Pandemic Security Initiative

Director of New Ventures

Geisel School of Medicine

Tillman Gerngross, PhD
Areas of Expertise: biomedical entrepreneurship, rapid antibody drug development

Professor of Bioengineering

Thayer School of Engineering

Co-founder and CEO, Adimab and Adagio Therapeutics

Daniel Wrapp GR’21
Areas of Expertise: structural biology, viral fusion proteins

PhD Candidate in Molecular and Cellular Biology

Guarini School of Graduate and Advanced Studies